CoChat

Weak Agonistic LPS Restores Intestinal Immune Homeostasis

Open access
Steimle, Alex, Michaelis, Lena, Di Lorenzo, Flaviana, Kliem, Thorsten, Münzner, Tobias, Maerz, Jan Kevin, Schäfer, Andrea, Lange, Anna, Parusel, Raphael, Gronbach, Kerstin, Fuchs, Kerstin, Silipo, Alba, Öz, Hasan Halit, Pichler, Bernd J., Autenrieth, Ingo B., Molinaro, Antonio, Frick, Julia-Stefanie · 2019 · Molecular Therapy
Cited by 96

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Generated by gram-negative bacteria, lipopolysaccharides (LPSs) are one of the most abundant and potent immunomodulatory substances present in the intestinal lumen. Interaction of agonistic LPS with the host myeloid-differentiation-2/Toll-like receptor 4 (MD-2/TLR4) receptor complex results in nuclear factor κB (NF-κB) activation, followed by the robust induction of pro-inflammatory immune responses. Here we have isolated LPS from a common gut commensal, Bacteroides vulgatus mpk (BVMPK), which provides only weak agonistic activity. This weak agonistic activity leads to the amelioration of inflammatory immune responses in a mouse model for experimental colitis, and it was in sharp contrast to strong agonists and antagonists. In this context, the administration of BVMPK LPS into mice with severe intestinal inflammation re-established intestinal immune homeostasis within only 2 weeks, resulting in the clearance of all symptoms of inflammation. These inflammation-reducing properties of weak agonistic LPS are grounded in the induction of a special type of endotoxin tolerance via the MD-2/TLR4 receptor complex axis in intestinal lamina propria CD11c + cells. Thus, weak agonistic LPS represents a promising agent to treat diseases involving pathological overactivation of the intestinal immune system, e.g., in inflammatory bowel diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2019.07.007

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 96

Metadata

Authors
Steimle, A., Michaelis, L., Di Lorenzo, F., Kliem, T., Münzner, T., Maerz, J. K., Schäfer, A., Lange, A., Parusel, R., Gronbach, K., Fuchs, K., Silipo, A., Öz, H. H., Pichler, B. J., Autenrieth, I. B., Molinaro, A., & Frick, J.-S.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2019-11
Volume
27
Issue
11
Pages
1974-1991
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2962804268
Cited by
96
References
15
FWCI
3.36
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Weak Agonistic LPS Restores Intestinal Immune Homeostasis. https://app.cochat.ai/papers/10.1016/j.ymthe.2019.07.007
The paper
Steimle, A., Michaelis, L., Di Lorenzo, F., Kliem, T., Münzner, T., Maerz, J. K., Schäfer, A., Lange, A., Parusel, R., Gronbach, K., Fuchs, K., Silipo, A., Öz, H. H., Pichler, B. J., Autenrieth, I. B., Molinaro, A., & Frick, J.-S. (2019). Weak Agonistic LPS Restores Intestinal Immune Homeostasis. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2019.07.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.